AR-12286 Ophthalmic Solution 0.5%

DRUG3 trials

Sponsors

Aerie Pharmaceuticals

Conditions

GlaucomaOcular HypertensionOpen Angle GlaucomaOpen-angle Glaucoma

Phase 2

AR-12286 in Combination With Latanoprost

CompletedNCT01302249

Aerie PharmaceuticalsGlaucoma, Ocular Hypertension

Start: 2011-02-28End: 2011-12-31Updated: 2014-05-08

A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months

CompletedNCT01699464

Aerie PharmaceuticalsOcular Hypertension, Open-angle Glaucoma

Start: 2012-10-31End: 2013-04-30Updated: 2023-08-22

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

CompletedNCT01789736

Aerie PharmaceuticalsOcular Hypertension, Open Angle Glaucoma

Start: 2013-02-28End: 2013-06-30Updated: 2014-03-17